DEST - Destiny Pharma making real progress
(NewsDirect)
Destiny Pharma PLC (AIM:DEST) chiefexecutive Neil Clark updates Proactive's Thomas Warner on thelatest news from the clinical-stage biotech company.
The update follows the announcement thatDestiny has reached a collaboration and co-development agreement forits phase 3 ready treatment for the prevention of C. difficileinfection (CDI) recurrence.
Clark says Destiny Pharma is"making real progess" and delivering on itsstrategy.
Contact Details
Proactive UKLtd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.